BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 927 filers reported holding BAXTER INTL INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $294,950 | -17.5% | 7,815 | -0.4% | 0.01% | -16.7% |
| Q2 2023 | $357,617 | +23.6% | 7,849 | +10.0% | 0.01% | +20.0% |
| Q1 2023 | $289,345 | -23.2% | 7,134 | -3.5% | 0.01% | -28.6% |
| Q4 2022 | $376,859 | +37585.9% | 7,394 | -38.2% | 0.01% | – |
| Q3 2022 | $1,000 | -99.8% | 11,968 | +89.5% | 0.00% | -100.0% |
| Q2 2022 | $406,000 | -10.6% | 6,314 | +7.8% | 0.01% | 0.0% |
| Q1 2022 | $454,000 | -15.5% | 5,857 | -6.3% | 0.01% | -18.2% |
| Q4 2021 | $537,000 | -15.3% | 6,252 | -20.7% | 0.01% | -8.3% |
| Q3 2021 | $634,000 | +33.2% | 7,882 | +33.2% | 0.01% | +9.1% |
| Q2 2021 | $476,000 | +0.4% | 5,918 | +5.3% | 0.01% | -15.4% |
| Q1 2021 | $474,000 | -18.4% | 5,621 | -22.4% | 0.01% | -31.6% |
| Q4 2020 | $581,000 | -2.2% | 7,242 | -1.9% | 0.02% | -13.6% |
| Q3 2020 | $594,000 | +15.8% | 7,381 | +23.9% | 0.02% | 0.0% |
| Q2 2020 | $513,000 | +11.0% | 5,958 | +4.7% | 0.02% | -12.0% |
| Q1 2020 | $462,000 | +2.0% | 5,688 | +4.7% | 0.02% | +31.6% |
| Q4 2019 | $453,000 | -7.0% | 5,435 | -1.9% | 0.02% | -13.6% |
| Q3 2019 | $487,000 | +4.1% | 5,543 | -3.1% | 0.02% | +4.8% |
| Q2 2019 | $468,000 | +2.0% | 5,720 | +1.0% | 0.02% | -8.7% |
| Q1 2019 | $459,000 | +51.5% | 5,662 | +24.2% | 0.02% | +27.8% |
| Q4 2018 | $303,000 | +4.5% | 4,560 | +21.9% | 0.02% | +28.6% |
| Q3 2018 | $290,000 | -14.5% | 3,740 | -19.4% | 0.01% | -30.0% |
| Q2 2018 | $339,000 | +10.1% | 4,643 | -1.0% | 0.02% | +5.3% |
| Q1 2018 | $308,000 | -4.9% | 4,692 | -7.6% | 0.02% | -5.0% |
| Q4 2017 | $324,000 | +11.7% | 5,079 | +9.0% | 0.02% | +17.6% |
| Q3 2017 | $290,000 | -1.4% | 4,658 | -4.5% | 0.02% | -5.6% |
| Q2 2017 | $294,000 | +11.8% | 4,877 | -3.0% | 0.02% | 0.0% |
| Q1 2017 | $263,000 | +30.2% | 5,026 | +8.7% | 0.02% | +20.0% |
| Q4 2016 | $202,000 | -62.0% | 4,624 | -58.7% | 0.02% | -63.4% |
| Q3 2016 | $531,000 | -35.8% | 11,200 | -38.3% | 0.04% | -35.9% |
| Q2 2016 | $827,000 | +19.0% | 18,156 | +6.4% | 0.06% | +10.3% |
| Q1 2016 | $695,000 | -23.3% | 17,060 | -27.8% | 0.06% | -24.7% |
| Q4 2015 | $906,000 | +66.9% | 23,633 | +42.7% | 0.08% | +48.1% |
| Q3 2015 | $543,000 | -45.1% | 16,556 | +16.7% | 0.05% | -38.1% |
| Q2 2015 | $989,000 | +124.3% | 14,183 | +120.7% | 0.08% | +104.9% |
| Q1 2015 | $441,000 | -56.4% | 6,427 | -53.2% | 0.04% | -58.6% |
| Q4 2014 | $1,012,000 | +57.4% | 13,743 | +53.4% | 0.10% | +102.0% |
| Q3 2014 | $643,000 | +27.6% | 8,961 | +28.3% | 0.05% | -14.0% |
| Q2 2014 | $504,000 | – | 6,987 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |